Pattern of Psychotropic Drug Use among Older Adults Having a Depression or an Anxiety Disorder: Results from the Longitudinal ESA Study

Abstract

Objective: To document the use of psychotropic drugs in Quebec older adult population with a depressive or anxiety disorder. Method: Data from the Enquête sur la Santé des Aînés (ESA) study conducted between 2005 and 2008 using a representative sample ( n = 1869) of community-dwelling adults aged 65 years and older were used to examine the use of psychotropic drugs in the Quebec older adult population. Results: Our results indicate that only 46.9% of the older adults with a diagnosis of depression or anxiety during the 24-month period studied according to the Régie de l'assurance maladie du Quebec (RAMQ) register used antidepressants (AD) for 400 days (12.9 months) on average during this period. Also, 59% of the RAMQ's mental health disorder patients used a mean daily dose of 5 mg of a diazepam equivalent for 338 days (10.9 months) on average during the same period. However, 10.0% of the older adults without any symptoms (ESA) at T1 and at T2 and any RAMQ depression and anxiety diagnosis between T0 and T2 were AD users during the 24-month period studied. They represent 26.2% of the AD users and consumed them for 494 days (15.9 months) on average during the 24-month period studied. Finally, the number of days of AD and benzodiazepine use was not associated with partial or total remission. Conclusions: This result questions the population effectiveness of these drugs in this population.